Evox Therapeutics

OverviewSuggest Edit

Evox Therapeutics is a biotechnology company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, to develop a new class of therapeutics. The Company creates substantial proprietary technology to modify exosomes using various molecular engineering, drug loading, and targeting strategies to facilitate targeted drug delivery to organs of interest, including the brain and the central nervous system.
TypePrivate
Founded2016
HQOxford, GB
Websiteevoxtherapeutics.com

Latest Updates

Employees (est.) (May 2020)56

Key People/Management at Evox Therapeutics

Antonin de Fougerolles

Antonin de Fougerolles

Chief Executive Officer and Director
Andrew McLean

Andrew McLean

Non-Executive Director
Per Lundin

Per Lundin

Chief Operating Officer and Co-Founder, Director
Sarah Gordon Wild

Sarah Gordon Wild

Non-Executive Director
Simon Dew

Simon Dew

VP Business Development
Bo Kara

Bo Kara

VP Process Development
Show more

Evox Therapeutics Office Locations

Evox Therapeutics has offices in Oxford and Solna
Oxford, GB (HQ)
Magdalen Centre, Robert Robinson Ave
Solna, SE
Karolinska Institutet Science Park, Hälsovägen 7
Show all (2)

Evox Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2016

Evox Therapeutics total Funding

$62.7 m

Evox Therapeutics latest funding size

$1.98 m

Time since last funding

a year ago

Evox Therapeutics investors

Evox Therapeutics's latest funding round in March 2019 was reported to be $2 m. In total, Evox Therapeutics has raised $62.7 m
Show all financial metrics

Evox Therapeutics Revenue

Cash (31-Dec-2018)

36.3m
GBPFY, 2016FY, 2017FY, 2018

Cash

8.9m5.3m36.3m

Accounts Receivable

151.0k350.0k

Current Assets

9.1m6.5m38.0m
Y, 2018

Financial Leverage

1 x
Show all financial metrics

Evox Therapeutics Online and Social Media Presence

Embed Graph

Evox Therapeutics News and Updates

Evox Therapeutics Appoints Martin Andrews as Non-Executive Director

OXFORD, England, May 27, 2020 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, is pleased to announce the appointment of Martin Andrews as a Non-Executive Director. Martin is a highly experienced senior pharmaceutical executive with...

Evox Therapeutics Expands Leadership Team With the Appointment of Two Experienced Life Sciences Executives

OXFORD, England, May 9, 2019 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, is pleased to announce the appointments of Bo Kara as VP Process Development and Simon Dew as VP of Business Development. Bo has over 30 years' experience...

Evox Therapeutics Awarded £1.5 Million in Funding From Innovate UK

OXFORD, England, March 22, 2019 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, today announces that it has secured £1.5 million in funding from Innovate UK, the UK's Innovation Agency, through the Biomedical Catalyst Early Stage...

Evox Therapeutics Appoints Edwin Moses as Non-Executive Chairman

OXFORD, England, December 20, 2018 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, is pleased to announce the appointment of Dr Edwin Moses as Non-Executive Chairman. Edwin will bring a wealth of experience to Evox, as the Company...

Evox Therapeutics to Expand Its Work on Cell-targeted Delivery of Nucleic Acid-based Drugs

OXFORD, England, December 10, 2018 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, today announces that it has secured an undisclosed amount of funding from the Bill & Melinda Gates Foundation. The funds will be used to support the...

Evox Therapeutics Named in The Sunday Times Fast Track Disruptors to Watch

OXFORD, England, December 3, 2018 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, was yesterday named in the list of The Sunday Times Fast Track Disruptors to Watch. Disruptors to Watch identifies ten of the most disruptive private...
Show more

Evox Therapeutics Blogs

Evox Therapeutics Frequently Asked Questions

  • When was Evox Therapeutics founded?

    Evox Therapeutics was founded in 2016.

  • Who are Evox Therapeutics key executives?

    Evox Therapeutics's key executives are Antonin de Fougerolles, Andrew McLean and Per Lundin.

  • How many employees does Evox Therapeutics have?

    Evox Therapeutics has 56 employees.

  • Who are Evox Therapeutics competitors?

    Competitors of Evox Therapeutics include Protalex, TrovaGene and Biocept.

  • Where is Evox Therapeutics headquarters?

    Evox Therapeutics headquarters is located at Magdalen Centre, Robert Robinson Ave, Oxford.

  • Where are Evox Therapeutics offices?

    Evox Therapeutics has offices in Oxford and Solna.

  • How many offices does Evox Therapeutics have?

    Evox Therapeutics has 2 offices.